Caelyx Adjuvant in Elderly Breast Cancer

NCT00284336 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Elderly

Interventions

DRUG: Caelyx
DRUG: endoxan

Sponsor

Universitaire Ziekenhuizen KU Leuven